Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.41 |
| ▸ | CHRNG | P07510 | 1/20 | 0.41 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | CHRND | Q07001 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8766773 | 0.81 | HSD11B1 (0.56) | HSD11B1MAOBMAOACNR2CHRNA1 | |
| SCHEMBL21002189 | 0.80 | KDM1A (0.49) | HSD11B1CNR2CHRNA1CHRNGCHRNB1 | |
| SCHEMBL30791157 | 0.80 | KDM1A (0.49) | HSD11B1CNR2CHRNA1CHRNGCHRNB1 | |
| SCHEMBL6899610 | 0.79 | HSD11B1 (0.54) | HSD11B1MAOBMAOACHRNA1CHRNG | |
| SCHEMBL18910952 | 0.79 | TSHR (0.47) | HSD11B1CNR2LMNA | |
| SCHEMBL18905305 | 0.78 | HSD11B1 (0.40) | HSD11B1CNR2LMNA | |
| SCHEMBL23221304 | 0.78 | HSD11B1 (0.53) | HSD11B1MAOBMAOACNR2EPHX2 | |
| SCHEMBL25611079 | 0.76 | HSD11B1 (0.51) | HSD11B1MAOBMAOACNR2CHRNA1 | |
| SCHEMBL6934361 | 0.76 | HSD11B1 (0.51) | HSD11B1MAOBMAOACNR2P2RX7 | |
| SCHEMBL26384419 | 0.76 | HSD11B1 (0.39) | HSD11B1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117185966-B | Method for carrying out open-loop sulfonylation on cycloalkanol | 安徽金桐精细化学有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-117185966-A | Method for carrying out open-loop sulfonylation on cycloalkanol | 安徽金桐精细化学有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-115806488-A | Method for ring-opening allylation of cycloalkanol | 南京工业大学 | 2023-03-17 | — | — | CN | disclosed |
| EP-1143964-B1 | 2-ADAMANTANEMETHANAMINE COMPOUNDS FOR TREATING ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RES LTD (GB) | 2004-03-24 | — | — | EP | disclosed |
| EP-1051392-B1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RES LTD (GB) | 2003-12-17 | — | — | EP | disclosed |
| US-6531511-B1 | N-methyl aspartate receptor antagonist | VERNALIS RESEARCH LIMITED (GB) | 2003-03-11 | — | — | US | disclosed |
| EP-1143964-A1 | 2-ADAMANTANEMETHANAMINE COMPOUNDS FOR TREATING ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RESEARCH LIMITED (GB) | 2001-10-17 | — | — | EP | disclosed |
| US-6262106-B1 | Adamantanecarboximidamide derivatives and their use as NMDA antagonists | VERNALIS RESEARCH LIMITED (GB) | 2001-07-17 | — | — | US | disclosed |
| EP-1051392-A1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 2000-11-15 | — | — | EP | disclosed |
| WO-2000044371-A1 | 2-ADAMANTANEMETHANAMINE COMPOUNDS FOR TREATING ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RESEARCH LIMITED (GB) | 2000-08-03 | — | — | WO | disclosed |
| WO-1999038841-A1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 1999-08-05 | — | — | WO | disclosed |